Close Menu

NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal third quarter revenues rose nearly 3 percent year over year, as reported, and 4 percent on a currency-neutral, organic adjusted basis.

For the three months ended June 30, the company posted revenues of $3.20 billion compared to $3.12 billion in the year-ago quarter, coming in just under Wall Street analysts' average estimate of $3.21 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.